Dr. Navin Pinto, MD
Claim this profileSeattle Children's Hospital
Expert in Neuroblastoma
Studies Lymphoma
24 reported clinical trials
38 drugs studied
Area of expertise
1Neuroblastoma
Global LeaderStage IV
APC negative
FBXW7 negative
2Lymphoma
MYC positive
Stage IV
BRD4 positive
Affiliated Hospitals
Clinical Trials Navin Pinto, MD is currently running
Nivolumab + Chemotherapy
for Nasopharyngeal Cancer
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Researchers want to find out what effects, good and/or bad, adding nivolumab to chemotherapy has on patients with newly diagnosed NPC. In addition, they want to find out if children with NPC may be treated with less radiation therapy and whether this decreases the side effects of therapy.
Recruiting1 award Phase 25 criteria
Iobenguane (131-I) + Vorinostat
for Neuroblastoma
This trial tests a combination of a radioactive drug and a cancer-fighting pill in patients with a specific type of neuroblastoma that hasn't responded well to other treatments. The radioactive drug kills cancer cells, and the pill makes them more vulnerable to the drug.
Recruiting1 award Phase 23 criteria
More about Navin Pinto, MD
Clinical Trial Related3 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Navin Pinto, MD has experience with
- Dinutuximab
- Cyclophosphamide
- 131I-MIBG
- Vincristine
- Gemcitabine
- Vorinostat
Breakdown of trials Navin Pinto, MD has run
Neuroblastoma
Lymphoma
Osteosarcoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Navin Pinto, MD specialize in?
Navin Pinto, MD focuses on Neuroblastoma and Lymphoma. In particular, much of their work with Neuroblastoma has involved Stage IV patients, or patients who are APC negative.
Is Navin Pinto, MD currently recruiting for clinical trials?
Yes, Navin Pinto, MD is currently recruiting for 6 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Navin Pinto, MD has studied deeply?
Yes, Navin Pinto, MD has studied treatments such as Dinutuximab, Cyclophosphamide, 131I-MIBG.
What is the best way to schedule an appointment with Navin Pinto, MD?
Apply for one of the trials that Navin Pinto, MD is conducting.
What is the office address of Navin Pinto, MD?
The office of Navin Pinto, MD is located at: Seattle Children's Hospital, Seattle, Washington 98105 United States. This is the address for their practice at the Seattle Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.